Studies have shown that miR-429 can enhance HCC cell migration and invasion by directly targeting the PTEN/PI3K/AKT/β-catenin pathway, with insufficient methylation in its promoter region believed to be a key initiator of these processes [52]. Here, AKT1 is linked to hepatocellular carcinoma.